Hemagen Diagnostics Total Assets

Hemagen Diagnostics (HMGN) currently reports a total assets of $2.4M as of September 2012. That compares with $2.9M in the prior-year period — down 15.4% year over year. Use the charts on this page to explore Hemagen Diagnostics's total assets history and peer comparisons.

Hemagen Diagnostics's total assets decreased from $2.9M to $2.4M — a 15.4% year-over-year decrease (period ending September 2012). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hemagen Diagnostics reported $2.4M in total assets as of September 2012. That compares with $2.9M in the prior-year period — down 15.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $2.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemagen Diagnostics, and consider following HMGN for alerts when major investors trade the stock.

Hemagen Diagnostics is classified in the Healthcare sector. On total assets, it currently shows $2.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HMGN with unrelated industries.